secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001193125-25-270490
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma prices $100M equity offering at $13.50/share (7.4M shares total)
--------------------------------------------------------------------------------

- Underwritten public offering of 5,930,000 shares plus 889,500-share underwriter option; concurrent registered direct offering of 1,481,481 shares to Suvretta Capital affiliates.
- Gross proceeds ~$100M; net proceeds to fund product candidate programs, working capital, and general corporate purposes.
- Offerings priced at $13.50 per share; expected to close Nov 7, 2025 subject to customary conditions.
- Company, execs, directors, and Suvretta Capital subject to 90-day lock-up on share sales after Nov 5, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312525270490/0001193125-25-270490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312525270490/d53447d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-270490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer